You Searched For "remdesivir patient" and got 15 results
Sort By:
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
How remdesivir drug can save lives in nations with lower hospital capacity
Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study o…
Remdesivir could reduce Covid mortality if given within 9 days of symptom onset, says new study
Remdesivir can reduce mortality in patients if administered within 9 days of COVID-19 symptom onset…
PTI
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…
Cipla launches generic remdesivir for COVID-19 patients
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
The WHO will not recommend remdesivir for COVID-19 patients, since it doesn't seem to boost their chances of survival
In a statement on Thursday, the World Health Organization said it will not recommend remdesivir bec…
Susie Neilson
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
US FDA approves emergency use of Remdesivir for COVID-19 patients
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the e…
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
Gilead tanks 9% on report its coronavirus drug doesn't help patients
The report contained "inappropriate characterizations," Gilead said, adding that low enrollment led…
Ben Winck
The utter chaos and confusion over Remdesivir in India is making the COVID-19 second wave worse
Remdesivir is not a proven treatment against COVID-19. Governments have said it, the courts hav…
Inside the treacherous black market for Remdesivir in India— from private hospitals to distributors
The black market for drugs that could treat COVID-19 is surging in India, especially when it comes …
Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs.
The National Institutes of Health announced a massive new study Friday to test 3 immune modulators …
Andrew Dunn
The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients
If the inhaled version of remdesivir works, it "could have significant implications in helping to s…